279 related articles for article (PubMed ID: 8988664)
1. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images.
Wong WL; Hussain K; Chevretton E; Hawkes DJ; Baddeley H; Maisey M; McGurk M
Am J Surg; 1996 Dec; 172(6):628-32. PubMed ID: 8988664
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
[TBL] [Abstract][Full Text] [Related]
4. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.
Balogova S; Périé S; Kerrou K; Grahek D; Montravers F; Angelard B; Susini B; El Chater P; St Guily JL; Talbot JN
Mol Imaging Biol; 2008; 10(6):364-73. PubMed ID: 18668293
[TBL] [Abstract][Full Text] [Related]
6. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
7. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
8. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
9. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Ito K; Yokoyama J; Miyata Y; Toyohara J; Okasaki M; Minamimoto R; Morooka M; Ishiwata K; Kubota K
Nucl Med Commun; 2015 Mar; 36(3):219-25. PubMed ID: 25369751
[TBL] [Abstract][Full Text] [Related]
10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
[TBL] [Abstract][Full Text] [Related]
12. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
[TBL] [Abstract][Full Text] [Related]
13. The impact of FDG PET on the management of occult primary head and neck tumours.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy.
Bailet JW; Abemayor E; Jabour BA; Hawkins RA; Ho C; Ward PH
Laryngoscope; 1992 Mar; 102(3):281-8. PubMed ID: 1545657
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
[TBL] [Abstract][Full Text] [Related]
17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
18. First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Burger IA; Zitzmann-Kolbe S; Pruim J; Friebe M; Graham K; Stephens A; Dinkelborg L; Kowal K; Schibli R; Luurtsema G; Maas B; Horn-Tutic M; Haerle SK; Wiegers J; Schaefer NG; Hany TF; von Schulthess GK
J Nucl Med; 2014 Nov; 55(11):1778-85. PubMed ID: 25256060
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
20. Influence of volumetric 4'-[methyl-
Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]